ArticleBMC infectious diseases2025
Time to a tuberculosis treatment cure and its predictors among tuberculosis patients at public health facilities in Arba minch town, South Ethiopia: A retrospective cohort study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe WHO’s 2024 Global tuberculosis (TB) Report shows that TB causes 1.25 million deaths annually, including 161,000 TB-Human Immunodeficiency Virus (HIV) infections. It affects 10.6 million people, mainly in Asia and Africa, 75% of whom are in the economically active age group of 15–54 years. Treatment interruptions hinder efforts to eliminate TB by 2030. According to a recent systematic review conducted using Ethiopian studies indicated that the pooled prevalence of TB treatment cure rate was 33.9%. There is a lack of evidence on time to TB treatment cure in Ethiopia using survival analysis.
objectiveThis study aimed to determine the time to TB treatment cure and its predictors among TB patients from January 2021 to December 2023 at public health facilities in Arba Minch town. South Ethiopia.
methodAn institution-based retrospective cohort study was conducted among 628 selected TB patients who were admitted to the TB care unit at Arba Minch General Hospital, Dilfana Primary Hospital, and both health centers from 2021 to 2023. A Kaplan Meier survival curve was fitted to test the survival time. The Cox proportional hazards model was used to identify predictors with TB treatment cure. Significance was considered at a p value ≤ 0.05 with an adjusted hazard ratio (AHR) 95% CI in the multivariate analysis.
resultsOut of the 628 patients whose records were analyzed, the median time to cure was 162 days. The significant predictors of time to TB cure included being male (AHR 0.3, 95% CI: 0.35–0.95), history of TB treatment (AHR 0.56, 95% CI: 0.35–0.95), normal BMI (AHR 1.04, 95% CI: 1.32–1.49) and attending at secondary heath facility (AHR 1.69, 95% CI: 1.40–2.00).
conclusionsSocio-demographic and clinical related factors were found to be independent predictors of time to cure. TB control programs should adopt gender-sensitive approaches to address delayed cure in male patients, integrate nutritional assessment into care and strengthen primary health facilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.